October 2022 - Page 4 of 7 - CannabisNewsWire

MondayOct 17, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffness Lexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medication Reasons advanced for the suboptimal adherence include lack of awareness or treatment, increased number of prescribed medications, and major adverse effects of the prescribed drugs Lexaria has so far shown that its DehydraTECH-CBD is…

MondayOct 17, 2022 9:00 am

Changing Legal Landscape for Cannabis in Colombia and the U.S. Portends a New Era of Productivity for Flora Growth Corp. (NASDAQ: FLGC)

Colombia and the United States have both recently exhibited new openness to the possibility of decriminalizing adult recreational cannabis use through legislative change Cannabis supplier Flora Growth cultivates its product at a key Colombian farm and provides it to international markets, and may see additional opportunities arise as cannabis policies advance in the two countries Flora Growth recently announced completion of its first shipments of high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate supplied to its market in the United States The company also recently reported a 604 percent YOY increase in revenues…

MondayOct 17, 2022 4:20 am

420 with CNW — Companies Scramble to Adapt as Marijuana Legalization Spreads

As more states across the United States establish legal marijuana markets, employers are scrambling to adjust to this new reality. This is because the traditional no-tolerance policies are becoming harder to enforce in the face of the changes brought by legalization. For instance, there is a current shortage of workers, particularly for lower-paying job opportunities. Pre-employment testing for marijuana is increasingly being seen as a barrier to getting even the few applicants interested in joining the workforce. Many companies are therefore suspending such pre-employment tests especially for jobs which aren’t safety sensitive, such as operating machinery or driving trucks. The…

FridayOct 14, 2022 4:20 pm

420 with CNW — Courts May Help Bring Federal Marijuana Legalization Closer

Despite President Joseph Biden having pardoned individuals convicted of simple cannabis convictions, he has shown no interest in loosening the federal restrictions that have left most states in control of developing how the billion-dollar marijuana industry in the country is growing. Thus far, 37 states in the country have legalized medical cannabis, with 19 of those states permitting individuals aged 21 and above to possess the drug for recreational use. However, the drug’s illegality at the federal level continues to prevent interstate sales. Various states have established their marijuana programs to meet objectives beyond legalization. For instance, many prioritize issuance…

FridayOct 14, 2022 4:20 am

420 with CNW — Federal Labor Secretary Promises to Assist Those Pardoned for Cannabis Crimes Find Jobs

Last week, a pair of cabinet members in the Biden administration discussed the president’s new marijuana initiative. Cabinet members and legislators, as well as advocates and state officials, have widely praised President Joseph Biden for his action. Marty Walsh, U.S. Labor Secretary, stated in an interview with Yahoo Finance that officials were working hard to make sure that individuals who received pardons for federal cannabis offenses under the decree made by President Biden weren’t hindered from employment opportunities in the future. Walsh explained that the Department of Labor was focused on ensuring that what the president said was carried out,…

ThursdayOct 13, 2022 4:20 pm

420 with CNW — Biden Health Secretary Tasked FDA to Move Quickly on Cannabis’ Scheduling Review

Xavier Becerra, the U.S. Health & Human Services Secretary, revealed during a Meet & Greet event in Tampa, Florida, that his agency is prepared to move quickly to implement the review of marijuana’s status as a Schedule 1 drug. This comes after President Joe Biden issued a directive ordering that the scheduling of marijuana in the Controlled Substances Act be reviewed. Speaking to reporters, the health secretary asserted that the nation will see the speed with which the review will be conducted. However, Becerra was quick to add that at the end of the day, science would be the deciding…

ThursdayOct 13, 2022 9:45 am

Lift&Co. Expo Cannabis Business Conference & Trade Show Releases Limited All-Access Presale Tickets for Vancouver 2023

Canada’s leading Cannabis Conference and Trade Show, Lift&Co. Expo, invites all members of the cannabis industry and community to its upcoming Vancouver event taking place January 12-14, 2023, at the Vancouver Convention Centre. For a limited time, Lift&Co. Expo is releasing a limited number of discounted Lift Cannabis Business Conference (“LCBC”) + Expo All-Access presale tickets for $350 (regularly priced at $599). Starting on day one, the Lift Cannabis Business Conference will tackle timely industry topics such as cannabis blockchain, brand and retailer relations, and cannabis real estate investing. It will also explore laws and regulations that need to change…

ThursdayOct 13, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complications Lexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participants Dominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026 In the United States, over 121.5 million adults are affected by high blood pressure – with statistics stacked against people of color, those with a family history of high…

ThursdayOct 13, 2022 4:20 am

420 with CNW — DEA Admits It Was Founded Based on Ethnic, Class and Racial Prejudice

These days, most pundits agree that the war on drugs is a failure. After decades of prohibition, the drug war has barely dented the illicit drug trade but contributed to the incarceration of thousands of Black people. Under prohibitionist policies, law enforcement waged a war on Black and Brown communities for decades in what some called the new Jim Crow. Black people were and still are four times more likely to be arrested for cannabis consumption despite similar use rates as White people, and they are subject to harsher sentences. Analysis of the cannabis-related arrests that occurred in the five…

WednesdayOct 12, 2022 4:20 pm

420 with CNW — FBI Arrest Data on Cannabis Full of Inconsistencies Despite Improvements Made to Reporting System

The Federal Bureau of Investigation has spent millions of tax dollars and the last seven years updating its reporting system for crime statistics. The use of the agency’s National Incident-Based Reporting System was meant to offer clear and nationally representative data on crime trends in the country. However, the new data doesn’t give complete information, especially concerning drug arrests across America during the past year. If anything, the end result for last year’s data raises questions for individuals tracking trends on drug enforcement, which include cannabis-related arrests. The FBI’s fragmented data on the criminalization of drugs still shows that marijuana…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Month: October 2022